This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Renzo Cecere Permission Requests Google Scholar Articles by Samoukovic, G. Articles by Cecere, R. PubMed PubMed Citation Articles by Samoukovic, G. Articles by Cecere, R.

The Impella^® LP 5.0 as a bridge to long-term circulatory support

^a Division of Cardiothoracic Surgery, McGill University Health Center, 687 Pine Avenue West, Montreal, Quebec H3A 1A1, S-8.44, Canada
^b Division of Cardiology, McGill University Health Center, 687 Pine Avenue West, Montreal, Quebec H3A 1A1, M4, Canada

*Corresponding author. Associate Professor of Surgery, McGill University, Surgical Director, Heart Failure and Thoracic Transplant Program, Director, Mechanical Cardiac Assist Program. Tel./fax: +1 514 934-1934.

E-mail address: renzo.cecere{at}muhc.mcgill.ca (R. Cecere).

Multi-organ failure (MOF) secondary to bi-ventricular cardiac dysfunction is a major therapeutic challenge. In addition to aggressive medical therapy, it frequently requires circulatory support with uni- or bi-ventricular assist devices. The Impella^® LP 5.0 is a new microaxial left ventricular assist device (LVAD). Microaxial LVADs have been used for short-term circulatory support in patients with cardiogenic shock due to myocarditis, post coronary artery bypass grafting (CABG), or during high-risk percutaneous coronary interventions (PCI). We present a case of a patient in bi-ventricular failure successfully bridged to permanent circulatory support. Relative merits of this therapeutic approach are outlined and discussed.

Key Words: Congestive heart failure; Mechanical circulatory support; Cardiac transplantation